# Stem Cell Transplantation for Patients With Cancers of the Blood

> **NCT00467961** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 61 (actual)

## Conditions studied

- CML (Chronic Myelogenous Leukemia)
- CLL (Chronic Lymphocytic Leukemia)
- AML (Acute Myelogenous Leukemia)
- Acute Lymphocytic Leukemia
- MDS (Myelodysplastic Syndrome)

## Interventions

- **COMBINATION_PRODUCT:** Miltenyi system

## Key facts

- **NCT ID:** NCT00467961
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2018-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00467961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00467961, "Stem Cell Transplantation for Patients With Cancers of the Blood". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00467961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*